Close Menu

MIT

The method permits the detection of mRNA transcripts of interest for more than 6,000 single cells in parallel per assay with high sensitivity and specificity; and has a variety of applications, including detecting replicating intracellular pathogens such as retroviruses.

Foundation Medicine has raised $25 million in Series A financing that it will use to "broadly analyze the relevant tumor genomic and other molecular information in individual patients' cancers and connect it with a knowledgebase of clinical data to help oncologists personalize treatment."

As part of its request for dismissal, MIT admitted no wrongdoing, but agreed to be bound by any court ruling against the case's other defendants, the Whitehead Institute for Biomedical Research and the University of Massachusetts Medical School.

Using a synthetic gene expression system in yeast, Massachusetts Institute of Technology researchers demonstrated that promoter noise and transcription factor instability can prompt bimodal gene expression.

Using a morphological classifier and computational method for integrating this data with information from an RNA interference screen, a group of researchers from the Massachusetts Institute of Technology and Harvard University delved into genetic interactions affecting the Rho signaling pathway in Drosophila.

The matter is of particular importance since UMass is the only one of the four organizations to which the IP is assigned to have licensed it to companies other than Alnylam.

Although the suit was first filed last summer, the courtroom showdown had been brewing for years.

The suit, filed by Alnylam and Max Planck against the University of Massachusetts, MIT, and the Whitehead Institute for Biomedical Research, is set to go to trial Feb. 22.

IP Roundup: Dec 22, 2009

Premium

Biocortech, Samsung Electronics, Massachusetts Institute of Technology, Agilent Technologies, Population Genetics Technologies, Life Technologies, Abbott Laboratories, Roche NimbleGen

The schools will study 14 plants to discover how genes affect their ability to produce compounds that are, or may be, used in drugs.

Pages

A tissue sample from the 1960s harbors a near-complete sample of HIV, IFLScience reports.

A new bill would reshape the US National Science Foundation to include a focus on technological development, according to Science.

The Food and Drug Administration's decision to halt a SARS-CoV-2 study has drawn criticism, according to Stat News.

In Genome Biology this week: features affecting gut microbiome and parasite patterns, cellular interactions in lung tumor microenvironment, and more.